Is circulating phospholipase A2 removed by large-pore continuous venovenous hemodiafiltration in septic acute renal failure?

Renal Failure

Volumn 26, Issue 2, 2004, Pages 127-133

  Terao, Yoshiaki ^a   Saito, Masataka ^b   Hara, Tetsuya ^b   Sumikawa, Koji ^b  

^a NAGASAKI ROSAI HOSPITAL   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute renal failure; Adsorption; Clearance; Continuous hemodiafiltration; Large pore membrane; Phospholipase A2; Sepsis; Western blot analysis

Indexed keywords

HEPARIN; MONOCLONAL ANTIBODY; PHOSPHOLIPASE A2; PHOSPHOLIPASE A;

ACUTE KIDNEY FAILURE; ADSORPTION; ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FILTER; HEMODIALYSIS; HUMAN; INFLAMMATION; LARGE PORE CONTINUOUS VENOVENOUS HEMODIAFILTRATION; MALE; PLASMA CLEARANCE; PRIORITY JOURNAL; SEPSIS; WESTERN BLOTTING; CASE CONTROL STUDY; COMPARATIVE STUDY; EPIDEMIOLOGY; FOLLOW UP; HEMODIAFILTRATION; HOSPITALIZATION; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; PROBABILITY; REFERENCE VALUE; RISK ASSESSMENT; SURVIVAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; PHOSPHOLIPASES A; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SAMPLING STUDIES; SEPSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 3142718835     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120038487     Document Type: Article

References (15)

1. Bulger, E.M.; Maier, R.V. Lipid mediators in the pathophysiology of critical illness. Crit. Care Med. 2000, 28 (4), N27-N36. Suppl.
2. 2 in patients in intensive care unit. J. Am. Coll. Surg. 1995, 180 (3), 323-331.
3. 2 levels with circulatory collapse. Crit. Care Med. 1988, 16 (4), 1-7.
4. Schetz, M.; Ferdinande, P.; Van den Berghe, G.; Verwaest, C.; Lauwers, P. Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense? Intensive Care Med. 1995, 21 (2), 169-176.
5. De Vriese, A.S.; Colardyn, F.A.; Philippe, J.J.; Vanholder, R.C.; DeSutter, J.H.; Lameire, N.H. Cytokine removal during continuous hemofiltration in septic patients. J. Am. Soc. Nephrol. 1999, 10 (4), 846-853.
6. Kline, J.A.; Gordon, B.E.; Williams, C.; Blumenthal, S.; Watts, J.A.; Diaz-Buxo, J. Large-pore hemodialysis in acute endotoxin shock. Crit. Care Med. 1999, 27 (3), 588-596.
7. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 1992, 20 (6), 864-874.
8. Thadhani, R.; Pascual, M.; Bonventre, J.V. Acute renal failure. N. Engl. J. Med. 1996, 334 (22), 1448-1460.
9. Knaus, W.A.; Draper, E.A.; Wagner, D.P.; Zimmerman, J.E. APACHE II: a severity of disease classification system. Crit. Care Med. 1985, 13 (10), 818-829.
10. 2 activity and prostacyclin synthesis in patients undergoing cardiac surgery. J. Clin. Invest. 1995, 95 (3), 1062-1070.
11. 2s in regulating arachidonic acid release. J. Biol. Chem. 1998, 273 (23), 14411-14423.
12. 2 activity in the tears of chronic blepharitis patients. Invest. Ophthalmol. Vis. Sci. 1999, 40 (11), 2744-2748.
13. 2. Biochim. Biophys. Acta 1989, 1005 (3), 270-276.
14. Yekebas, E.F.; Treede, H.; Knoefel, W.T.; Bloechle, C.; Fink, E.; Izbicki, J.R. Influence of zero-balanced hemofiltration on the course of severe experimental pancreatitis in pigs. Ann. Surg. 1999, 229 (4), 514-522.
15. Katayama, H. Comparison of continuous renal replacement therapy by clearance measurement. Journal of the Japanese Society of Intensive Care Medicine 1998, 5 (2), 115-121.